Background: Plantar fasciitis accounts for 11 to 15% of all foot problems in adults. It peaks in 40 to 60 years of age group and in younger age group, commonly among runners. Plantar fasciitis causes heel pain in both active and sedentary adults of all ages. It is the most common degenerative disease for the cause of heel pain and a self limiting disease that affects most of the adult age group in most southern parts of India. Though NSAIDs, steroids, botulinum toxin –A and shock wave therapy have shown better results in plantar fasciitis, they carry potential risk of serious complications and functional disability. Objectives: To evaluate pain following Platelet rich plasma injection in plantar fasciitis among adults in a tertiary care centre. Methodology: A Hospital based non – randomized trial (NRT) was conducted among 30 adults (18 – 50 years) in the Orthopaedic out – patient department of GSL Medical College, Rajahmundry, for a period of six months. Results: Mean age of the study subjects was 37.5+ 9.17 years. About two – third of the subjects had duration of symptoms for 7-12 months. All the patients with pain for more than 12 months duration had complete pain relief. Response to autologous PRP injection is statistically significant in patients with chronic plantar fasciitis. Conclusions: Autologous PRP injection is a safe and useful modality for treatment of chronic plantar fasciitis.
Introduction: A presence or consequences of the plantar spur as a cause of plantar fasciitis are currently uncertain. But literature is deficient with conflicting findings regarding the relationship between the PS and PF. The study was undertaken to assess the incidence of types and sizes of the plantar spurs and to find the relationship between the plantar spur and plantar fasciitis. Material & Methods: We studied 30 patients with the complaints of plantar fasciitis having plantar spur were included. Length and size of the plantar spur were assessed radiologically using lateral view ankle X-rays. Pain and functional assessment were evaluated using VAS and AOFAS score before and after treatment. Results: Length of the plantar spur was classified as type 0/absent in 4 patients, 1/small in 4 patients, 2/medium in 12 patients and 3/large in 10 patients Plantar spur size was measure spurs as 10mm. The highest incidence spurs size was 5-10mm and >10mm accounts for 36.67% each (n=11). Statistically, significant improvement was found in the mean VAS and AOFAS score in all the patients after treatment especially patient with a medium sized spur (grade 2).Cohen's Kappa statistic showed excellent intra and inter-observer agreement. Conclusions: These suggest that the presence or consequences of the plantar spur are not necessarily as a cause of plantar fasciitis. These results may enlighten the knowledge to understand the role of the plantar spur in a patient with plantar fasciitis.